The pharmacologic effects of beta 2-adrenoceptor agonist drugs, including vilanterol, are at least in part attributable to stimulation of intracellular adenyl cyclase, the enzyme that catalyzes ...

Developed with US respiratory specialist firm Innoviva, the drug (known as Breo Ellipta in the US) is GSK’s follow up to its respiratory blockbuster Advair/Seretide, but won’t come close to ...

"As CMS continues to evolve its drug price negotiation programme ... ICER has published the research protocol (PDF) for the evaluation of Breo Ellipta and Trelegy Ellipta – which made £1.1 ...

With prices finalized for the first 10 Medicare Part D drugs selected for the initial ... first time with their blockbusters, ...